<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:36:06Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7400690" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7400690</identifier>
        <datestamp>2020-08-11</datestamp>
        <setSpec>f1000res</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">F1000Res</journal-id>
              <journal-id journal-id-type="iso-abbrev">F1000Res</journal-id>
              <journal-id journal-id-type="pmc">F1000Research</journal-id>
              <journal-title-group>
                <journal-title>F1000Research</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2046-1402</issn>
              <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7400690</article-id>
              <article-id pub-id-type="pmcid">PMC7400690</article-id>
              <article-id pub-id-type="pmc-uid">7400690</article-id>
              <article-id pub-id-type="pmid">32789011</article-id>
              <article-id pub-id-type="doi">10.12688/f1000research.24051.1</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group>
                  <subject>Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Optimised patient information materials and recruitment to a study of behavioural activation in older adults: an embedded study within a trial</article-title>
                <fn-group content-type="pub-status">
                  <fn>
                    <p>[version 1; peer review: 2 approved]</p>
                  </fn>
                </fn-group>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Knapp</surname>
                    <given-names>Peter</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Data Curation</role>
                  <role content-type="http://credit.casrai.org/">Formal Analysis</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Writing – Original Draft Preparation</role>
                  <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5904-8699</contrib-id>
                  <xref ref-type="corresp" rid="c1">a</xref>
                  <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gilbody</surname>
                    <given-names>Simon</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Funding Acquisition</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
                  <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Holt</surname>
                    <given-names>Janet</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
                  <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Keding</surname>
                    <given-names>Ada</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Formal Analysis</role>
                  <role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
                  <xref ref-type="aff" rid="a1">1</xref>
                  <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Mitchell</surname>
                    <given-names>Natasha</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Project Administration</role>
                  <role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
                  <xref ref-type="aff" rid="a1">1</xref>
                  <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Raynor</surname>
                    <given-names>David K.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
                  <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Silcock</surname>
                    <given-names>Jonathan</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
                  <xref ref-type="aff" rid="a4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Torgerson</surname>
                    <given-names>David</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
                  <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1667-4275</contrib-id>
                  <xref ref-type="aff" rid="a1">1</xref>
                  <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <aff id="a1"><label>1</label>Department of Health Sciences and the Hull York Medical School, University of York,, York, UK</aff>
                <aff id="a2"><label>2</label>School of Healthcare, University of Leeds, Leeds, UK</aff>
                <aff id="a3"><label>3</label>Department of Health Sciences, University of York, York, UK</aff>
                <aff id="a4"><label>4</label>School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK</aff>
              </contrib-group>
              <author-notes>
                <corresp id="c1">
                  <label>a</label>
                  <email xlink:href="mailto:peter.knapp@york.ac.uk">peter.knapp@york.ac.uk</email>
                </corresp>
                <fn fn-type="COI-statement">
                  <p><bold>Competing interests: </bold>One of the authors, D K Raynor, is an academic advisor to Luto Research Limited, that undertook user testing for the study. </p>
                </fn>
              </author-notes>
              <pub-date pub-type="epub">
                <day>21</day>
                <month>5</month>
                <year>2020</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2020</year>
              </pub-date>
              <volume>9</volume>
              <elocation-id>417</elocation-id>
              <history>
                <date date-type="accepted">
                  <day>18</day>
                  <month>5</month>
                  <year>2020</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright: © 2020 Knapp P et al.</copyright-statement>
                <copyright-year>2020</copyright-year>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="f1000research-9-26530.pdf"/>
              <abstract>
                <p><bold>Background: </bold>Printed participant information about randomised controlled trials is often long, technical and difficult to navigate. Improving information materials is possible through optimisation and user-testing, and may impact on participant understanding and rates of recruitment.</p>
                <p><bold>Methods: </bold>A study within a trial (SWAT) was undertaken within the CASPER trial. Potential CASPER participants were randomised to receive either the standard trial information or revised information that had been optimised through information design and user testing.</p>
                <p><bold>Results: </bold>A total of 11,531 patients were randomised in the SWAT. Rates of recruitment to the CASPER trial were 2.0% in the optimised information group and 1.9% in the standard information group (odds ratio 1.027; 95% CI 0.79 to 1.33; p=0.202).</p>
                <p><bold>Conclusions: </bold>Participant information that had been optimised through information design and user testing did not result in any change to rate of recruitment to the host trial.</p>
                <p><bold>Registration: </bold>ISRCTN ID
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/ISRCTN02202951">ISRCTN02202951</ext-link>; registered on 3 June 2009.</p>
              </abstract>
              <kwd-group kwd-group-type="author">
                <kwd>SWAT</kwd>
                <kwd>trial</kwd>
                <kwd>recruitment</kwd>
                <kwd>patient information</kwd>
                <kwd>user testing</kwd>
                <kwd>behavioral activation</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="fund-1" xlink:href="http://dx.doi.org/10.13039/501100000272">
                  <funding-source>National Institute for Health Research</funding-source>
                  <award-id>HTA08/19/04</award-id>
                </award-group>
                <funding-statement>UK National Institute of Health Research Health Technology Assessment Programme (project number 08/19/04).</funding-statement>
                <funding-statement>
                  <italic>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</italic>
                </funding-statement>
              </funding-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro">
              <title>Introduction</title>
              <p>Potential participants in randomised controlled trials are given information that is often long, technical and difficult to navigate
<sup><xref rid="ref-1" ref-type="bibr">1</xref>–
<xref rid="ref-3" ref-type="bibr">3</xref></sup>. Consequently, they may lack understanding of important details about the trial
<sup><xref rid="ref-1" ref-type="bibr">1</xref>,
<xref rid="ref-4" ref-type="bibr">4</xref>,
<xref rid="ref-5" ref-type="bibr">5</xref></sup>, which limits their ability to make an informed decision about consent.</p>
              <p>Improving information materials is possible through optimisation and user-testing. This involves making changes to the design and text based on good practice in information design and people’s ability to find and understand information during testing
<sup><xref rid="ref-6" ref-type="bibr">6</xref></sup>. Materials revised after user-testing have been shown to be preferred
<sup><xref rid="ref-7" ref-type="bibr">7</xref>,
<xref rid="ref-8" ref-type="bibr">8</xref></sup>, although a recent review concluded that optimised information has little or no impact on trial recruitment
<sup><xref rid="ref-9" ref-type="bibr">9</xref></sup>. However, the evidence base remains limited
<sup><xref rid="ref-10" ref-type="bibr">10</xref>–
<xref rid="ref-13" ref-type="bibr">13</xref></sup>, and a recent ‘review of reviews’ reported that information for patients can be a facilitator of research participation
<sup><xref rid="ref-14" ref-type="bibr">14</xref></sup>.</p>
              <sec>
                <title>Study aims</title>
                <p>This embedded study within a trial (SWAT) assesses whether optimisation of patient information materials through user testing could increase participant recruitment to the CASPER study
<sup><xref rid="ref-15" ref-type="bibr">15</xref></sup>.</p>
              </sec>
            </sec>
            <sec sec-type="methods">
              <title>Methods</title>
              <sec>
                <title>Design</title>
                <p>The SWAT was conducted within CASPER, which investigated the effectiveness of behavioural activation in patients aged 65 years or older with sub-threshold levels of depression
<sup><xref rid="ref-15" ref-type="bibr">15</xref></sup>. CASPER used a cohort multiple randomised controlled trial design
<sup><xref rid="ref-16" ref-type="bibr">16</xref></sup>.</p>
              </sec>
              <sec sec-type="subjects">
                <title>Participants</title>
                <p>Participants were registered patients at one of six UK medical practices in Durham, Harrogate, Leeds and York. They were included if they were potentially eligible for CASPER.</p>
              </sec>
              <sec>
                <title>Intervention</title>
                <p>All participants in the SWAT were posted an invitation letter, participant information sheet (PIS), screening questionnaire and consent form for the CASPER trial. The control group received the standard CASPER developed PIS (see
<italic>Extended data</italic>)
<sup><xref rid="ref-17" ref-type="bibr">17</xref></sup> whilst the intervention group were sent an optimised version (see
<italic>Extended data</italic>)
<sup><xref rid="ref-18" ref-type="bibr">18</xref></sup> developed through three rounds of user testing and revision.</p>
                <p>Patients returned the questionnaire and a consent form indicating a willingness to participate, after which they were recruited to the CASPER cohort. Following a telephone diagnostic interview, eligible patients were recruited to the CASPER intervention trial.</p>
              </sec>
              <sec>
                <title>User testing</title>
                <p>User testing involved 30 people reflecting the CASPER target population. In the first round of testing, 10 participants read the standard invitation letter and PIS. They were then asked to locate and demonstrate their understanding of 18 items of information within the PIS (on the study’s nature and purpose; process and meaning of consent; study procedures; nature of the CASPER trial intervention). The PIS was then revised based on participant responses. A second round of testing was completed, in which 10 new participants read the invitation letter and a revised PIS and were asked to find and show understanding of the same 18 information items. The PIS was further revised and tested on 10 new participants through the same 18 information items.</p>
                <p>Through testing, changes to the PIS included adding a title page, a summary of key points and a contents page, highlighting headings using colour and larger font, and simplifying wording. The final optimised PIS was printed as an A4 booklet (Figure 3).</p>
              </sec>
              <sec>
                <title>Outcomes</title>
                <p>The primary outcome measure was the proportion of patients in each group who were recruited to the CASPER trial. The secondary outcomes were (i) the proportion of patients recruited to the CASPER cohort, and (ii) the proportion of invited patients returning forms to express interest in participation in CASPER.</p>
              </sec>
              <sec>
                <title>Sample size</title>
                <p>It was predicted that 30% of invited patients would return the consent form and indicate interest in CASPER participation, of whom 20% (600) would be eligible to take part in the CASPER trial. An improvement in response rate of 10% (i.e. from 30% to 33% participants) would be a significant increase in uptake. A sample size of 8,000 potential participants would be sufficient at 80% power to detect a difference of 10% in recruitment rate.</p>
              </sec>
              <sec>
                <title>Randomisation</title>
                <p>Individual patients were allocated randomly (1:1) to receive either the standard or optimised PIS by an independent statistician at York Trials Unit.</p>
              </sec>
              <sec>
                <title>Statistical analysis</title>
                <p>Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were calculated to compare the proportion of patients from each group that were recruited to the CASPER trial; recruited to the CASPER cohort; or expressed interest in participation. Analyses were conducted in Stata version 14.2.</p>
              </sec>
              <sec>
                <title>Approvals</title>
                <p>CASPER and the SWAT were approved by the NHS Leeds North-East Research Ethics Committee (10/H1306/61).</p>
              </sec>
            </sec>
            <sec sec-type="results">
              <title>Results</title>
              <p>Overall, 11,531 patients were invited to participate
<sup><xref rid="ref-19" ref-type="bibr">19</xref></sup>; 5,765 (50.0%) were randomised to the optimised PIS and 5,766 (50.0%) to the standard PIS (
<xref ref-type="fig" rid="f1">Figure 1</xref>).</p>
              <fig fig-type="figure" id="f1" orientation="portrait" position="anchor">
                <label>Figure 1. </label>
                <caption>
                  <title>Flow diagram of recruitment to the CASPER trial.</title>
                </caption>
                <graphic xlink:href="f1000research-9-26530-g0000"/>
              </fig>
              <p>A total of 2,169 patients returned the consent form indicating a willingness to take part: 1,102 (19.1%) in the optimised PIS group and 1,067 (18.5%) in the standard PIS group (odds ratio (OR) 1.04; 95% confidence interval (CI) 0.95 to 1.14; p=0.402).</p>
              <p>A total of 229 patients were recruited to the CASPER trial: 116 (2.0% of those invited) in the optimised PIS group and 113 (1.9%) in the standard PIS group (OR 1.027; 95% CI 0.79 to 1.33; p=0.202).</p>
              <p>In total, 1,667 patients expressed interest in participating but were ineligible for the CASPER trial and were recruited to the CASPER cohort: 851 (14.8% of those invited) in the optimised PIS group, and 816 (14.1%) in the standard PIS group (OR 1.05; 95% CI 0.95 to 1.16).</p>
            </sec>
            <sec sec-type="discussion">
              <title>Discussion</title>
              <p>Optimisation of the PIS resulted in no statistically significant difference in the rates of recruitment to the CASPER trial or CASPER cohort, or rates of consent form returns. This is consistent with previous research
<sup><xref rid="ref-9" ref-type="bibr">9</xref></sup>, including other embedded trials within the MRC START programme, which have observed little or no effect on recruitment
<sup><xref rid="ref-11" ref-type="bibr">11</xref>–
<xref rid="ref-13" ref-type="bibr">13</xref>,
<xref rid="ref-20" ref-type="bibr">20</xref></sup>.</p>
              <p>Whilst there was no impact on recruitment, the optimised materials may have improved understanding of the trial thus enabling patients to make a more informed decision. Improved comprehension could also increase retention, due to greater understanding of the trial prior to recruitment. These outcomes were not assessed and further research examining this is warranted.</p>
            </sec>
            <sec sec-type="conclusions">
              <title>Conclusion</title>
              <p>Optimised patient information materials did not increase recruitment to the host trial or expressions of interest in participation.</p>
            </sec>
            <sec sec-type="data-availability">
              <title>Data availability</title>
              <sec>
                <title>Underlying data</title>
                <p>Figshare: CASPER SWAT data.csvCASPER SWAT recruitment data and evaluated information sheets.
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.12302672">https://doi.org/10.6084/m9.figshare.12302672</ext-link>
<sup><xref rid="ref-20" ref-type="bibr">20</xref></sup>.</p>
                <p>This project contains the underlying data</p>
              </sec>
              <sec>
                <title>Extended data</title>
                <p>Figshare: Figure 2 CASPER PIS (original).
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.12302675">https://doi.org/10.6084/m9.figshare.12302675</ext-link>
<sup><xref rid="ref-17" ref-type="bibr">17</xref></sup>.</p>
                <p>This file is the original CASPER participant information sheet.</p>
                <p>Figshare: Figure 3 CASPER PIS (revised).
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.12302678">https://doi.org/10.6084/m9.figshare.12302678</ext-link>
<sup><xref rid="ref-18" ref-type="bibr">18</xref></sup>.</p>
                <p>This file is the revised CASPER participant information sheet.</p>
              </sec>
              <sec>
                <title>Reporting guidelines</title>
                <p>Figshare: CONSORT checklist for ‘Optimised patient information materials and recruitment to a study of behavioural activation in older adults: an embedded study within a trial’.
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.12312206.v1">https://doi.org/10.6084/m9.figshare.12312206.v1</ext-link>
<sup><xref rid="ref-21" ref-type="bibr">21</xref></sup>.</p>
                <p>Data are available under the terms of the
<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/legalcode">Creative Commons Attribution 4.0 International license</ext-link> (CC-BY 4.0).</p>
              </sec>
            </sec>
          </body>
          <back>
            <ack>
              <title>Acknowledgements</title>
              <p>The authors would also like to thank the embedded trial participants and the CASPER study team, particularly Helen Lewis. We thank Luto Research Limited (
<email xlink:href="mailto:luto.co.uk">luto.co.uk</email>) for undertaking the user testing, and Making Sense (
<email xlink:href="mailto:makingsense.co.uk">makingsense.co.uk</email>) for graphic design input.</p>
            </ack>
            <ref-list>
              <ref id="ref-1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>E</given-names></name><name><surname>Foe</surname><given-names>G</given-names></name><name><surname>Lally</surname><given-names>R</given-names></name></person-group>:
<article-title>Reading level and length of written research consent forms.</article-title><source><italic toggle="yes">Clin Transl Sci.</italic></source><year>2015</year>;<volume>8</volume>(<issue>4</issue>):<fpage>355</fpage>–<lpage>356</lpage>.
<pub-id pub-id-type="doi">10.1111/cts.12253</pub-id>
<!--<pub-id pub-id-type="pmcid">5351029</pub-id>-->
<?supplied-pmid 25580939?><pub-id pub-id-type="pmid">25580939</pub-id></mixed-citation>
              </ref>
              <ref id="ref-2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manta</surname><given-names>CJ</given-names></name><name><surname>Ortiz</surname><given-names>J</given-names></name><name><surname>Moulton</surname><given-names>BW</given-names></name><etal/></person-group>:
<article-title>From the Patient Perspective, Consent Forms Fall Short of Providing Information to Guide Decision Making.</article-title><source><italic toggle="yes">J Patient Saf.</italic></source><year>2016</year>.
<pub-id pub-id-type="doi">10.1097/PTS.0000000000000310</pub-id><!--<pub-id pub-id-type="pmcid">5290300</pub-id>--><?supplied-pmid 27490160?><pub-id pub-id-type="pmid">27490160</pub-id></mixed-citation>
              </ref>
              <ref id="ref-3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montalvo</surname><given-names>W</given-names></name><name><surname>Larson</surname><given-names>E</given-names></name></person-group>:
<article-title>Participant comprehension of research for which they volunteer: a systematic review.</article-title><source><italic toggle="yes">J Nurs Scholarsh.</italic></source><year>2014</year>;<volume>46</volume>(<issue>6</issue>):<fpage>423</fpage>–<lpage>431</lpage>.
<pub-id pub-id-type="doi">10.1111/jnu.12097</pub-id>
<?supplied-pmid 25130209?><pub-id pub-id-type="pmid">25130209</pub-id></mixed-citation>
              </ref>
              <ref id="ref-4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>JM</given-names></name><name><surname>Struve</surname><given-names>JK</given-names></name><name><surname>Collins</surname><given-names>D</given-names></name><etal/></person-group>:
<article-title>Long term clinical trials: how much information do participants retain from the informed consent process?.</article-title><source><italic toggle="yes">Contemp Clin Trials.</italic></source><year>2006</year>;<volume>27</volume>(<issue>5</issue>):<fpage>441</fpage>–<lpage>448</lpage>.
<pub-id pub-id-type="doi">10.1016/j.cct.2006.04.006</pub-id>
<?supplied-pmid 16798101?><pub-id pub-id-type="pmid">16798101</pub-id></mixed-citation>
              </ref>
              <ref id="ref-5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortun</surname><given-names>P</given-names></name><name><surname>West</surname><given-names>J</given-names></name><name><surname>Chalkley</surname><given-names>L</given-names></name><etal/></person-group>:
<article-title>Recall of informed consent information by healthy volunteers in clinical trials.</article-title><source><italic toggle="yes">QJM.</italic></source><year>2008</year>;<volume>101</volume>(<issue>8</issue>):<fpage>625</fpage>–<lpage>629</lpage>.
<pub-id pub-id-type="doi">10.1093/qjmed/hcn067</pub-id>
<?supplied-pmid 18487271?><pub-id pub-id-type="pmid">18487271</pub-id></mixed-citation>
              </ref>
              <ref id="ref-6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raynor</surname><given-names>DK</given-names></name><name><surname>Knapp</surname><given-names>P</given-names></name><name><surname>Silcock</surname><given-names>J</given-names></name><etal/></person-group>:
<article-title>"User-testing" as a method for testing the fitness-for-purpose of written medicine information.</article-title><source><italic toggle="yes">Patient Educ Couns.</italic></source><year>2011</year>;<volume>83</volume>(<issue>3</issue>):<fpage>404</fpage>–<lpage>10</lpage>.
<pub-id pub-id-type="doi">10.1016/j.pec.2011.03.016</pub-id>
<?supplied-pmid 21530140?><pub-id pub-id-type="pmid">21530140</pub-id></mixed-citation>
              </ref>
              <ref id="ref-7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knapp</surname><given-names>P</given-names></name><name><surname>Raynor</surname><given-names>DK</given-names></name><name><surname>Silcock</surname><given-names>J</given-names></name><etal/></person-group>:
<article-title>Performance-based readability testing of participant information for a Phase 3 IVF trial.</article-title><source><italic toggle="yes">Trials.</italic></source><year>2009</year>;<volume>10</volume>(<issue>1</issue>):<fpage>79</fpage>.
<pub-id pub-id-type="doi">10.1186/1745-6215-10-79</pub-id><!--<pub-id pub-id-type="pmcid">2743679</pub-id>--><?supplied-pmid 19723335?><pub-id pub-id-type="pmid">19723335</pub-id></mixed-citation>
              </ref>
              <ref id="ref-8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knapp</surname><given-names>P</given-names></name><name><surname>Raynor</surname><given-names>DK</given-names></name><name><surname>Silcock</surname><given-names>J</given-names></name><etal/></person-group>:
<article-title>Can user testing of a clinical trial patient information sheet make it fit-for-purpose?--a randomized controlled trial.</article-title><source><italic toggle="yes">BMC Med.</italic></source><year>2011</year>;<volume>9</volume>:<fpage>89</fpage>.
<pub-id pub-id-type="doi">10.1186/1741-7015-9-89</pub-id><!--<pub-id pub-id-type="pmcid">3152894</pub-id>--><?supplied-pmid 21777435?><pub-id pub-id-type="pmid">21777435</pub-id></mixed-citation>
              </ref>
              <ref id="ref-9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treweek</surname><given-names>S</given-names></name><name><surname>Pitkethly</surname><given-names>M</given-names></name><name><surname>Cook</surname><given-names>J</given-names></name><etal/></person-group>:
<article-title>Strategies to improve recruitment to randomised trials.</article-title><source><italic toggle="yes">Cochrane Database Syst Rev.</italic></source><year>2018</year>;<volume>2</volume>:<fpage>Mr000013</fpage>.
<pub-id pub-id-type="doi">10.1002/14651858.MR000013.pub6</pub-id><!--<pub-id pub-id-type="pmcid">7078793</pub-id>--><?supplied-pmid 29468635?><pub-id pub-id-type="pmid">29468635</pub-id></mixed-citation>
              </ref>
              <ref id="ref-10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Rahimi</surname><given-names>K</given-names></name><name><surname>Haynes</surname><given-names>R</given-names></name><etal/></person-group>:
<article-title>Investigating strategies to improve attendance at screening visits in a randomized trial.</article-title><source><italic toggle="yes">Trials.</italic></source><year>2011</year>;<volume>12</volume>(<issue>1</issue>):<fpage>A111</fpage><pub-id pub-id-type="doi">10.1186/1745-6215-12-S1-A111</pub-id><!--<pub-id pub-id-type="pmcid">3287684</pub-id>--></mixed-citation>
              </ref>
              <ref id="ref-11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Man</surname><given-names>MS</given-names></name><name><surname>Rick</surname><given-names>J</given-names></name><name><surname>Bower</surname><given-names>P</given-names></name><etal/></person-group>:
<article-title>Improving recruitment to a study of telehealth management for long-term conditions in primary care: two embedded, randomised controlled trials of optimised patient information materials.</article-title><source><italic toggle="yes">Trials.</italic></source><year>2015</year>;<volume>16</volume>(<issue>1</issue>):<fpage>309</fpage>.
<pub-id pub-id-type="doi">10.1186/s13063-015-0820-0</pub-id><!--<pub-id pub-id-type="pmcid">4506607</pub-id>--><?supplied-pmid 26187378?><pub-id pub-id-type="pmid">26187378</pub-id></mixed-citation>
              </ref>
              <ref id="ref-12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cockayne</surname><given-names>S</given-names></name><name><surname>Fairhurst</surname><given-names>C</given-names></name><name><surname>Adamson</surname><given-names>J</given-names></name><etal/></person-group>:
<article-title>An optimised patient information sheet did not significantly increase recruitment or retention in a falls prevention study: an embedded randomised recruitment trial.</article-title><source><italic toggle="yes">Trials.</italic></source><year>2017</year>;<volume>18</volume>(<issue>1</issue>):<fpage>144</fpage>.
<pub-id pub-id-type="doi">10.1186/s13063-017-1797-7</pub-id><!--<pub-id pub-id-type="pmcid">5370466</pub-id>--><?supplied-pmid 28351376?><pub-id pub-id-type="pmid">28351376</pub-id></mixed-citation>
              </ref>
              <ref id="ref-13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>A</given-names></name><name><surname>Knapp</surname><given-names>P</given-names></name><name><surname>Treweek</surname><given-names>S</given-names></name><etal/></person-group>:
<article-title>The effect of optimised patient information materials on recruitment in a lung cancer screening trial: an embedded randomised recruitment trial.</article-title><source><italic toggle="yes">Trials.</italic></source><year>2018</year>;<volume>19</volume>(<issue>1</issue>):<fpage>503</fpage>.
<pub-id pub-id-type="doi">10.1186/s13063-018-2896-9</pub-id><!--<pub-id pub-id-type="pmcid">6145341</pub-id>--><?supplied-pmid 30227890?><pub-id pub-id-type="pmid">30227890</pub-id></mixed-citation>
              </ref>
              <ref id="ref-14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheridan</surname><given-names>R</given-names></name><name><surname>Martin-Kerry</surname><given-names>J</given-names></name><name><surname>Hudson</surname><given-names>J</given-names></name><etal/></person-group>:
<article-title>Why do patients take part in research? An overview of systematic reviews of psychosocial barriers and facilitators.</article-title><source><italic toggle="yes">Trials.</italic></source><year>2020</year>;<volume>21</volume>:<fpage>259</fpage>.
<pub-id pub-id-type="doi">10.1186/s13063-020-4197-3</pub-id><!--<pub-id pub-id-type="pmcid">7069042</pub-id>--><?supplied-pmid 32164790?><pub-id pub-id-type="pmid">32164790</pub-id></mixed-citation>
              </ref>
              <ref id="ref-15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbody</surname><given-names>S</given-names></name><name><surname>Lewis</surname><given-names>H</given-names></name><name><surname>Adamson</surname><given-names>J</given-names></name><etal/></person-group>:
<article-title>Effect of Collaborative Care vs Usual Care on Depressive Symptoms in Older Adults With Subthreshold Depression: The CASPER Randomized Clinical Trial.</article-title><source><italic toggle="yes">JAMA.</italic></source><year>2017</year>;<volume>317</volume>(<issue>7</issue>):<fpage>728</fpage>–<lpage>737</lpage>.
<pub-id pub-id-type="doi">10.1001/jama.2017.0130</pub-id>
<?supplied-pmid 28241357?><pub-id pub-id-type="pmid">28241357</pub-id></mixed-citation>
              </ref>
              <ref id="ref-16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Relton</surname><given-names>C</given-names></name><name><surname>Torgerson</surname><given-names>D</given-names></name><name><surname>O’Cathain</surname><given-names>A</given-names></name><etal/></person-group>:
<article-title>Rethinking pragmatic randomised controlled trials: introducing the “cohort multiple randomised controlled trial” design.</article-title><source><italic toggle="yes">BMJ.</italic></source><year>2010</year>;<volume>340</volume>:<fpage>c1066</fpage>.
<pub-id pub-id-type="doi">10.1136/bmj.c1066</pub-id><?supplied-pmid 20304934?><pub-id pub-id-type="pmid">20304934</pub-id></mixed-citation>
              </ref>
              <ref id="ref-17">
                <label>17</label>
                <mixed-citation publication-type="data"><person-group person-group-type="author"><name><surname>Knapp</surname><given-names>P</given-names></name><name><surname>Gilbody</surname><given-names>S</given-names></name><name><surname>Holt</surname><given-names>J</given-names></name><etal/></person-group>:
<article-title>Figure 2 CASPER PIS (original).</article-title><source><italic toggle="yes">figshare.</italic></source>Figure.<year>2020</year><pub-id pub-id-type="doi">10.6084/m9.figshare.12302675.v1</pub-id></mixed-citation>
              </ref>
              <ref id="ref-18">
                <label>18</label>
                <mixed-citation publication-type="data"><person-group person-group-type="author"><name><surname>Knapp</surname><given-names>P</given-names></name><name><surname>Gilbody</surname><given-names>S</given-names></name><name><surname>Keding</surname><given-names>A</given-names></name><etal/></person-group>:
<article-title> Figure 3 CASPER PIS (revised).</article-title><source><italic toggle="yes">figshare.</italic></source>Figure.<year>2020</year><pub-id pub-id-type="doi">10.6084/m9.figshare.12302678.v1</pub-id></mixed-citation>
              </ref>
              <ref id="ref-19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knapp</surname><given-names>P</given-names></name><name><surname>Gilbody</surname><given-names>G</given-names></name><name><surname>Holt</surname><given-names>J</given-names></name><etal/></person-group>:
<article-title>Optimised patient information materials and recruitment to a study of behavioural activation in older adults: an embedded study within a trial (dataset)</article-title>.
<pub-id pub-id-type="doi">10.6084/m9.figshare.12302672</pub-id></mixed-citation>
              </ref>
              <ref id="ref-20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rick</surname><given-names>J</given-names></name><name><surname>Graffy</surname><given-names>J</given-names></name><name><surname>Knapp</surname><given-names>P</given-names></name><etal/></person-group>:
<article-title>Systematic techniques for assisting recruitment to trials (START): study protocol for embedded, randomized controlled trials.</article-title><source><italic toggle="yes">Trials.</italic></source><year>2014</year>;<volume>15</volume>:<fpage>407</fpage>.
<pub-id pub-id-type="doi">10.1186/1745-6215-15-407</pub-id><!--<pub-id pub-id-type="pmcid">4230578</pub-id>--><?supplied-pmid 25344684?><pub-id pub-id-type="pmid">25344684</pub-id></mixed-citation>
              </ref>
              <ref id="ref-21">
                <label>21</label>
                <mixed-citation publication-type="data"><person-group person-group-type="author"><name><surname>Knapp</surname><given-names>P</given-names></name><name><surname>Gilbody</surname><given-names>S</given-names></name><name><surname>Holt</surname><given-names>J</given-names></name><etal/></person-group>:
<article-title>CONSORT 2010 Checklist Knapp et al.</article-title><source><italic toggle="yes">figshare.</italic></source>Journal contribution.<year>2020</year><pub-id pub-id-type="doi">10.6084/m9.figshare.12312206.v1</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
          <sub-article id="report67713" article-type="peer-review">
            <front-stub>
              <article-id pub-id-type="doi">10.5256/f1000research.26530.r67713</article-id>
              <title-group>
                <article-title>Reviewer response for version 1</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Treweek</surname>
                    <given-names>Shaun P.</given-names>
                  </name>
                  <xref ref-type="aff" rid="r67713a1">1</xref>
                  <role>Referee</role>
                  <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7239-7241</contrib-id>
                </contrib>
                <aff id="r67713a1"><label>1</label>Health Services Research Unit, Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK</aff>
              </contrib-group>
              <author-notes>
                <fn fn-type="COI-statement">
                  <p><bold>Competing interests: </bold>I do collaborate with some of the authors, though not on the evaluation described in this paper. I was part of the MRC START project mentioned in the Discussion.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="epub">
                <day>3</day>
                <month>8</month>
                <year>2020</year>
              </pub-date>
              <permissions>
                <copyright-statement>Copyright: © 2020 Treweek SP</copyright-statement>
                <copyright-year>2020</copyright-year>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <related-article related-article-type="peer-reviewed-article" id="d38e1578" ext-link-type="doi" xlink:href="10.12688/f1000research.24051.1">Version 1</related-article>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>recommendation</meta-name>
                  <meta-value>approve</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>This is a well-written article describing a large, well done SWAT. I only have a few comments, which are listed below.</p>
              <p>
                <bold>Study aims</bold>
              </p>
              <p> The authors might want to add a sentence (and possibly a reference) that explains in brief what a SWAT is.</p>
              <p>
                <bold>Methods</bold>
              </p>
              <p><italic>Design</italic>– linked to the host trial ‘cohort multiple randomised controlled trial design’. This design is sometimes called a ‘Trials Within Cohort (TwiCs)' design. The authors might want to mention this name too, just in case readers are more familiar with it.  </p>
              <p><italic>User testing</italic>– the authors mention users were asked to locate and demonstrate understanding of 18 items of information within the participant information leaflet. I wasn’t sure what the 18 items were. Would it be possible to list them? Apologies if I have missed them within the article or extended data.</p>
              <p><italic>Randomisation</italic>– could the authors give a little more information on how the randomisation sequence was generated?</p>
              <p>
                <bold>Discussion</bold>
              </p>
              <p> The authors mention that their results are consistent with previous research, which is my understanding of the literature too. Do the authors think further evaluation of this SWAT evaluation is required, and if so, could they give some pointers to what sorts of evaluations would add most value to the evidence base?</p>
              <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
              <p>Yes</p>
              <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
              <p>Yes</p>
              <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
              <p>Yes</p>
              <p>Is the study design appropriate and is the work technically sound?</p>
              <p>Yes</p>
              <p>Are the conclusions drawn adequately supported by the results?</p>
              <p>Yes</p>
              <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
              <p>Yes</p>
              <p>Reviewer Expertise:</p>
              <p>Randomised trial methodology, including SWATs.</p>
              <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
            </body>
          </sub-article>
          <sub-article id="report67160" article-type="peer-review">
            <front-stub>
              <article-id pub-id-type="doi">10.5256/f1000research.26530.r67160</article-id>
              <title-group>
                <article-title>Reviewer response for version 1</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Clarke</surname>
                    <given-names>Mike J.</given-names>
                  </name>
                  <xref ref-type="aff" rid="r67160a1">1</xref>
                  <role>Referee</role>
                  <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2926-7257</contrib-id>
                </contrib>
                <aff id="r67160a1"><label>1</label>Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Institute of Clinical Sciences, Block B, Royal Hospital, Queen's University Belfast, Belfast, UK</aff>
              </contrib-group>
              <author-notes>
                <fn fn-type="COI-statement">
                  <p><bold>Competing interests: </bold>I have worked with some of the authors of this paper on the SWAT concept and Trial Forge. I am one of the people who developed the "SWAT" concept (and gave it this name) and established the SWAT repository.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="epub">
                <day>30</day>
                <month>7</month>
                <year>2020</year>
              </pub-date>
              <permissions>
                <copyright-statement>Copyright: © 2020 Clarke MJ</copyright-statement>
                <copyright-year>2020</copyright-year>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <related-article related-article-type="peer-reviewed-article" id="d38e1711" ext-link-type="doi" xlink:href="10.12688/f1000research.24051.1">Version 1</related-article>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>recommendation</meta-name>
                  <meta-value>approve</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>This is an impressive and important piece of methodology research, which has been reported in a clear and succinct manner. I am pleased to have been asked to review it.</p>
              <p> The reported randomized trial is an example of a very large SWAT, that was embedded in the CASPER trial of behavioural activation therapy for older patients with sub-threshold levels of depression, to test the impact on recruitment of an optimized information materials for people being invited to consider participation in the clinical trial.</p>
              <p> It might be helpful to readers if the authors could include a little more information about the SWAT concept, perhaps by citing one or both of the relevant Trial Forge papers: (a) Treweek S, Bevan S, Bower P, et al. Trial Forge Guidance 1: what is a Study Within A Trial (SWAT)? Trials 2018; 19: 139; and (b) Treweek S, Bevan S, Bower P, et al. Trial Forge Guidance 2: how to decide if a further Study Within A Trial (SWAT) is needed. Trials 2020; 21: 33.</p>
              <p> Although the optimized information materials did not improve the proportion of invitees who were recruited into CASPER, it would be interesting to know if there were other benefits, such as a better understanding of the clinical trial. The paper concludes with some comments about this but the authors' comment that “further research examining this is warranted” seems to suggest that this type of qualitative research might not be done with the CASPER trial patients. However, given that they will be collecting retention data for CASPER, I hope they will revisit this SWAT later in the CASPER trial to answer their own question about the potential for an impact on retention.</p>
              <p> If they have not already done so, I suggest that the authors register this SWAT in the SWAT repository. It might also help readers if they referred to two similar SWAT that are already registered there (SWAT 101 and SWAT 105).</p>
              <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
              <p>Yes</p>
              <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
              <p>Yes</p>
              <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
              <p>Yes</p>
              <p>Is the study design appropriate and is the work technically sound?</p>
              <p>Yes</p>
              <p>Are the conclusions drawn adequately supported by the results?</p>
              <p>Yes</p>
              <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
              <p>Yes</p>
              <p>Reviewer Expertise:</p>
              <p>Health services research. Randomized trials. Systematic reviews. Methodology research.</p>
              <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
            </body>
          </sub-article>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
